Susquehanna Fundamental Investments, LLC Oric Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $42,975 - $71,489	-13,643 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $58,566 - $207,690	-12,900 Reduced 48.6%	13,643 $73,000
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $61,779 - $104,423	5,144 Added 24.04%	26,543 $390,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $340,244 - $539,682	21,399 New	21,399 $447,000

125

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $315M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.